z-logo
open-access-imgOpen Access
Arctigenin Attenuates Ischemia/Reperfusion Induced Ventricular Arrhythmias by Decreasing Oxidative Stress in Rats
Author(s) -
Jing Yang,
HongShan Yin,
Yajing Cao,
Zhian Jiang,
Yongjun Li,
Mu-chun Song,
YongFei Wang,
Zhihua Wang,
Rong Yang,
Yunfa Jiang,
JinPeng Sun,
Boyi Liu,
Chuan Wang
Publication year - 2018
Publication title -
cellular physiology and biochemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.486
H-Index - 87
eISSN - 1421-9778
pISSN - 1015-8987
DOI - 10.1159/000493038
Subject(s) - malondialdehyde , medicine , ventricular fibrillation , ventricular tachycardia , superoxide dismutase , oxidative stress , ischemia , glutathione peroxidase , myocardial infarction , cardiology , anesthesia , pharmacology
Arctigenin (ATG) has been shown to possess anti-inflammatory, immunemodulatory, anti-viral, anti-microbial, anti-carcinogenic, vasodilatory and anti-platelet aggregation properties. However, the protective role of ATG in prevention of arrhythmias induced by myocardial ischemia/reperfusion is unknown. The aim of this study was to investigate the anti-arrhythmia effect of ATG in an ischemia/reperfusion injured rat heart model and explore the related mechanisms.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom